[Therapeutic effect of anti-nucleokine monoclonal antibody on ischemic brain infarction].

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1248/YAKUSHI.129.25PMID 19122433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of HMGB1 on ischemia-reperfusion injury in the rat heart.

  2008cited by this paper
• Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats

  2007cited by this paper
• High mobility group box 1 protein interacts with multiple Toll-like receptors.

  2006cited by this paper
• HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2

  2006cited by this paper
• High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

  2005cited by this paper
• A Peroxisome Proliferator-Activated Receptor-&ggr; Agonist Reduces Infarct Size in Transient but Not in Permanent Ischemia

  2005cited by this paper
• The "cytokine profile": a code for sepsis.

  2005cited by this paper
• S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature).

  2004cited by this paper
• A Combined Treatment with Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

  2002cited by this paper
• Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion Injury: Mechanical Versus Embolic Focal Ischemia in Spontaneously Hypertensive Rats

  2002cited by this paper
• Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia

  2001cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation.

  1993cited by this paper
• Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats.

  1992cited by this paper
• Effect of MCI-186 on brain edema in rats.

  1989cited by this paper
• Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

  1986cited by this paper
• Oxygen and glucose consumption related to Na+-K+ transport in canine brain.

  1981cited by this paper

• The Role of HMGB1 in Cardiovascular Biology: Danger Signals

  2015cites this paper
• Cerebellar Purkinje cells exhibit increased expression of HMGB-1 and apoptosis in congenital hydrocephalic H-Tx rats.

  2013cites this paper
• Expression analysis of high mobility group box-1 protein (HMGB-1) in the cerebral cortex, hippocampus, and cerebellum of the congenital hydrocephalus (H-Tx) rat.

  2012cites this paper
• Toll-like receptors in cerebral ischemic inflammatory injury

  2011cites this paper
• High-Mobility Group Protein Box-1 and its Relevance to Cerebral Ischemia

  2010cites this paper
• Targeting HMGB1/TLR4 signaling as a novel approach to treatment of cerebral ischemia.

  2010influential citation
• Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis.

  2010influential citation
• Therapeutic Effect of anti-Nucleokine Monoclonal Antibody on Ischemic Brain Infarction

  2009cites this paper